Literature DB >> 23818232

Low frequency of TERT promoter somatic mutation in 313 sporadic esophageal squamous cell carcinomas.

Yuda Zhao1, Yibo Gao, Zhaoli Chen, Xueda Hu, Fang Zhou, Jie He.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23818232     DOI： 10.1002/ijc.28360

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  10 in total

Review 1.  Telomerase promoter mutations in cancer: an emerging molecular biomarker?

Authors:  João Vinagre; Vasco Pinto; Ricardo Celestino; Marta Reis; Helena Pópulo; Paula Boaventura; Miguel Melo; Telmo Catarino; Jorge Lima; José Manuel Lopes; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  Virchows Arch       Date:  2014-07-22       Impact factor: 4.064

Review 2.  Personalized targeted therapy for esophageal squamous cell carcinoma.

Authors:  Xiaozheng Kang; Keneng Chen; Yicheng Li; Jianying Li; Thomas A D'Amico; Xiaoxin Chen
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines.

Authors:  Masahiro Hirata; Koji Fujita; Shintaro Fujihara; Takaaki Mizuo; Ryota Nakabayashi; Toshiaki Kono; Daisuke Namima; Naoki Fujita; Hiroki Yamana; Hideki Kamada; Joji Tani; Hideki Kobara; Kunihiko Tsutsui; Yoko Matsuda; Masafumi Ono; Tsutomu Masaki
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

4.  Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor.

Authors:  Marcin M Machnicki; Anna Rzepakowska; Joanna I Janowska; Monika Pepek; Alicja Krop; Katarzyna Pruszczyk; Piotr Stawinski; Malgorzata Rydzanicz; Jakub Grzybowski; Barbara Gornicka; Maciej Wnuk; Rafal Ploski; Ewa Osuch-Wojcikiewicz; Tomasz Stoklosa
Journal:  Front Oncol       Date:  2022-05-19       Impact factor: 5.738

Review 5.  Understanding TERT Promoter Mutations: A Common Path to Immortality.

Authors:  Robert J A Bell; H Tomas Rube; Ana Xavier-Magalhães; Bruno M Costa; Andrew Mancini; Jun S Song; Joseph F Costello
Journal:  Mol Cancer Res       Date:  2016-03-03       Impact factor: 5.852

6.  Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.

Authors:  Russell J Diefenbach; Jenny H Lee; Ashleigh Stewart; Alexander M Menzies; Matteo S Carlino; Robyn P M Saw; Jonathan R Stretch; Georgina V Long; Richard A Scolyer; Helen Rizos
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

7.  The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.

Authors:  Tiantian Liu; Taylor C Brown; C Christofer Juhlin; Adam Andreasson; Na Wang; Martin Bäckdahl; James M Healy; Manju L Prasad; Reju Korah; Tobias Carling; Dawei Xu; Catharina Larsson
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 8.  Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene.

Authors:  Muhammad Khairul Ramlee; Jing Wang; Wei Xun Toh; Shang Li
Journal:  Genes (Basel)       Date:  2016-08-18       Impact factor: 4.096

Review 9.  Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.

Authors:  Steffen Heeg
Journal:  Pharmgenomics Pers Med       Date:  2015-12-04

Review 10.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.